Articles by Susan J. Schniepp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan J. Schniepp

The Human Error Behind Human Error

A thorough investigation of all possible causes of deviations should be performed.
Feb 2, 2013

A thorough investigation of all possible causes of deviations should be performed.

Advice for Enhancing the Client–Sponsor Relationship

Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.
Nov 2, 2012

Key talks from the recent PDA/FDA regulatory conference highlight room for improvement.

35th Anniversary Special: The Transformation of Regulation and Global Standards

How FDA, USP, and ICH have redirected industry practice.
Jul 2, 2012

How FDA, USP, and ICH have redirected industry practice.

Know the Regulations

The contract provider needs to know as much as the NDA holder.
Apr 2, 2012

The contract provider needs to know as much as the NDA holder.

Managing the Quality Relationship for a Contractual Agreement

The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments.
Feb 1, 2012

The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments.

Auditing by the Numbers

Contract organizations must have highly organized teams and plans to accommodate today's audits.
Dec 2, 2011

Contract organizations must have highly organized teams and plans to accommodate today's audits.

Where in the World is the US Pharmacopeia?

After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.
Sep 2, 2011

After a series of structural changes, the author wonders whether USP is undergoing an identity crisis. USP CEO Roger L. Williams responds.

Following our Own Instructions

Why SOPs are rarely followed, often cited, and in need of follow-through.
Jun 2, 2011

Why SOPs are rarely followed, often cited, and in need of follow-through.

Insider Solutions: Reporting Equipment Changes

What to do when your CMO changes the manufacturing equipment line.
Mar 2, 2011

What to do when your CMO changes the manufacturing equipment line.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
25%
To select processes for both new and legacy products
20%
Do not use QbD
23%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here